MATERIALS

AND METHODS
Patients and Controls
Sera from seven unselected patients with TTP were studied during the acute episodes before treatment.
All patients had thrombocytopenia and schistocytic hemolytic anemia. Twenty milliliters of whole blood was collected from different healthy donors into acid citrate dextrose, pH 4.5, (6: 1, vol/vol). The platelet-rich plasma (PRP) was obtained by centnifugation ( I 60 g for 20 minutes). The PRP was incubated with '4C serotonin (Amersham, Oakville, Ontario) for 30 minutes at 37 #{176}C at a concentration of 0.5 Ci "C serotonin per mL PRP. Approximately 50% of the "C serotonin was taken up by the washed platelets giving a final specific activity of 1.84 x l0' zCi of "C serotonin per 106 platelets. The platelets were pelleted by centrifugation (1800 g for nine minutes) and resuspended in 10 mL of calcium and albumin-free Tyrode's solution, pH 6.2, containing 50 L of apyrase.
The apyrase (50 zg/mL) was prepared using standard techniques and inhibited aggregation induced by 10 izmol/L ADP. The platelets were washed once by centrifugation (I 200 g for seven minutes) and resuspended to a final count of 600,000/ L in albuminfree Tyrode's solution, pH 7.4. Because the reactivity of the platelet preparations occasionally differed from donor to donor, platelets were collected from three ABO compatible donors, pooled and processed as described above. In a second series of experiments the platelets were resuspended with human fibrinogen (Kabi, Sweden) at a final concentration of 2 mg/mL.
In these studies the assay was performed at 37 #{176}C and the effects of inhibitors of aggregation and release investigated as described subsequently.
In these experiments the cryoprecipitate preparation was not added. In these experiments the four TTP sera that were used were selected because their strong reactivity did not require the addition of the preparation rich in vWF to induce the release reaction.
The same experiment was repeated using the same T'l'P and control sera except that the IgG or control serum was preincubated with the platelets (22 #{176}C for 20 minutes) before addition of the TTP sera.
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